Effects of alendronate on the proliferation and osteogenic differentiation of MG-63 cells

Journal of International Medical Research

Volumn 37, Issue 2, 2009, Pages 407-416

  Xiong, Y ^a   Yang, H J ^b   Feng, J ^a   Shi, Z L ^a   Wu, Li Dong ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Zhejiang Traditional Chinese Medical Hospital   (China)

Author keywords

Alendronate; Bisphonates; Bone morphogenetic protein Z; MG 63 osteoblast like cell line; Mineralization; Osteogenic differentiation

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ALENDRONIC ACID; ALIZARIN RED S; ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; CALCIUM; COLLAGEN TYPE 1; OSTEOCALCIN; ANTHRAQUINONE DERIVATIVE; FORMAZAN; MTT FORMAZAN; TETRAZOLIUM;

ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CELL LINE; CELL MATURATION; CELL PROLIFERATION; COLORIMETRY; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; ENZYME ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; OSTEOBLAST; OSTEOLYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STAINING; BONE DEVELOPMENT; BONE MINERALIZATION; CYTOLOGY; ENZYMOLOGY; METABOLISM;

ALENDRONATE; ALKALINE PHOSPHATASE; ANTHRAQUINONES; CALCIFICATION, PHYSIOLOGIC; CELL DIFFERENTIATION; CELL PROLIFERATION; COLORIMETRY; FORMAZANS; HUMANS; OSTEOBLASTS; OSTEOGENESIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TETRAZOLIUM SALTS;

EID: 66649092722     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000903700216     Document Type: Article

References (30)

1. Russell RG, Rogers MJ: Bisphosphonates: from the laboratory to the clinic and back again. Bone 1999; 25: 97-106.
2. Rodan GA, Martin TJ: Therapeutic approaches to bone diseases. Science 2000; 289: 1508-1514.
3. Bell NH, Johnson RH: Bisphosphonates in the treatment of osteoporosis. Endocrine 1997; 6: 203-206.
4. Morris CD, Einhorn TA: Bisphosphonates in orthopaedic surgery. J Bone Joint Surg Am 2005; 87: 1609-1618.
5. Luckman SP, Hughes DE, Coxon FP, et al: Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP binding proteins, including Ras. J Bone Miner Res 1998; 13: 581-589.
6. van Beek E, Lowik C, van der Pluijm G, et al: The role of geranylgeranylation in bone resorption and its suppression by bisphosphonates in fetal bone explants in vitro: a due to the mechanism of action of nitrogen-containing bisphosphonates. J Bone Miner Res 1999; 14: 722-729.
7. Reszka AA, Rodan GA: Nitrogen-containing bisphosphonate mechanism of action. Mini Rev Med Chem 2004; 4: 711-719.
8. Rodan GA, Fleisch HA: Bisphosphonates: mechanisms of action. J Clin Invest 1996; 97: 2692-2696.
9. Giuliani N, Pedrazzoni M, Passert G, et al: Bisphosphonates inhibit IL-6 production by human osteoblast-like cells. Scand J Rheumatol 1998; 27: 38-41.
10. Vitté C, Fleisch H, Guenther HL: Bisphosphonates induce osteoblasts to secrete an inhibitor of osteoclast-cediated resorption. Endocrinology 1996; 137: 2324-2333.
11. Nishikawa M, Akatsu T, Katayama Y, et al: Bisphosphonates act on osteoblast cells and inhibit osteoclast formation in mouse marrow cultures. Bone 1996; 18: 9-14.
12. Sanhi M, Guenther HL, Fleisch H, et al: Bisphosphonates act on rat bone resorption through the mediation of osteoblast. J Clin Invest 1993; 91: 2004-2011.
13. Pan B, Farrugia AN, To LB, et al: The nitrogen-containing bisphosphonates, zoledronic acid, influences RANK1. expression in human osteoblast-like cells by activating TNF-alpha converting enzyme (TACE). J Bone Miner Res 204; 19: 147-154.
14. Mundy G, Garrett R, Harris S, et al: Stimulation of bone formation in vivo and in rodents by statins. Science 1999; 286: 1946-1949.
15. Luckman SP, Hughes DE, Coxon FP, et al: Nitrogen-containing bisphophonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras. J Bone Miner Res 1998; 13: 581-589.
16. Itoh F, Aoyagi S, Furihata-Komatsu H, et al: Clodrinate stimulates osteoblast differentaition In ST2 and MC3T3-E1 cells and rat organ cultures. Eur J Pharmacol 2003; 477: 9-16.
17. Garciá-Moreno C, Serrano S, Nacher M, et al: Effect of alendronate on cultural normal human osteoblasts. Bone 1998; 22: 233-239.
18. D'Aoust P, McCulloch CA, Tenebaum HC, et al: Etidronate (HEBP) promotes osteoblast differentiation and wound closure in rat calvaria. Cell Tissue Res 2000; 302: 353-363.
19. Klein BY, Ben-Bassat H, Breuer E, et al: Structurally different bisphosphonates exert opposing effects on alkaline phosphatase and mineralization in marrow osteoprogenitors. J Cell Biochem 1998; 68: 186-194.
20. Reinholz GG, Getz B, Pederson L, et al: Bisphosphonates directly regulate cell expression, differentiation, and gene expression in human osteoblasts. Cancer Res 2000; 60: 6001-6007.
21. Rodan GA, Seedor JG, Balena R: Preclinical pharmacology of alendronate. Osteoporos Int 1993; 3(suppl 3): s7-s12.
22. Frank O, Heim M, Jakob M, et al: Real-time quantitative RT-PCR analysis of human bone marrow stromal cells during osteogenic differentiation in vitro. J Cell Biochem 2002; 85: 737-746.
23. Mikami Y, Omoteyama K, Kato S, et al: Inductive effects of dexamethasone on the mineralization and the osteoblastic gene expressions in mature osteoblast-like ROS17/2.8 cells. Biochem Biophys Res Commun 2007; 362: 368-373.
24. Bukowski JF, Dascher CC, Das H: Alternative bisphosphonate targets and mechanisms of action. Biochem Biophys Res Commun 2005; 328: 746-750.
25. Guiliani N, Pedrazzoni M, Negri G, et al: Bisphosphonates stimulate formation of osteoblasts precursors and mineralized nodules in murine and human bone marrow cultures in young and aged mice in vivo. Bone 1998; 22: 455-461.
26. Im GI, Qureshi SA, Kenney J, et al: Osteoblast proliferation and maturation by bisphosphonates. Biomaterials 2004; 25: 4015-4115.
27. von Knoch F, Jaquiery C, Kowalsky M, et al: Effects of bisphosphonates on proliferation and osteoblast differentiation of human bone marrow stromal cells. Biomaterial 2005; 26: 6941-6949.
28. Mathov I, Plotkin LI, Sgarlata CL, et al: Extracellular signal-regulated kinases and calcium channels are involved in the proliferative effect of bisphosphonates on osteoblastic cells in vitro. J Bone Miner Res 2001; 16: 2050-2056.
29. Fujita T, Izumo N, Fukuyama R, et al: Incadronate and etidronate accelerate phosphate primed mineralization of MC4 cells via ERK1/2-cbfa1 sugnaling pathway in a Ras-independent manner: further involvement of mevalonate-pathway blockade for incadronate. Jpn J Pharmacol 2001; 86: 86-96.
30. Reinholz GG, Getz B, Sanders Es, et al: Distinct mechanisms of bisphosphonates action between potent new bisphosphonate analogue. Breast Cancer Res Treat 2002; 71: 257-268.